FDA Drug recall D-155-2013
Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam…
- FDA Drug
- Class I
- terminated
- Published 2013-02-13
On 2013-02-13 the FDA classified a Class I recall of Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam… by Matrixx Initiatives, citing microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-155-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2012-12-18 |
| Published | 2013-02-13 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Matrixx Initiatives |
| Distribution | US |
Product
Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.
Reason
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
Identifiers
| upc | 732216204100 |
|---|---|
| code_info | Lot # 2J23, Exp 09/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-155-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.